CA2171276A1 - Use of human recombinant interleukin-1 receptor antagonist and composition containing the latter for the treatment of osteoarthritis and composition containing said compound - Google Patents

Use of human recombinant interleukin-1 receptor antagonist and composition containing the latter for the treatment of osteoarthritis and composition containing said compound

Info

Publication number
CA2171276A1
CA2171276A1 CA002171276A CA2171276A CA2171276A1 CA 2171276 A1 CA2171276 A1 CA 2171276A1 CA 002171276 A CA002171276 A CA 002171276A CA 2171276 A CA2171276 A CA 2171276A CA 2171276 A1 CA2171276 A1 CA 2171276A1
Authority
CA
Canada
Prior art keywords
composition containing
receptor antagonist
human recombinant
osteoarthritis
recombinant interleukin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002171276A
Other languages
French (fr)
Other versions
CA2171276C (en
Inventor
Jean-Pierre Pelletier
Johanne Martel-Pelletier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ascentia Pharma Inc
Original Assignee
Jean-Pierre Pelletier
Johanne Martel-Pelletier
Ascentia Pharma Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jean-Pierre Pelletier, Johanne Martel-Pelletier, Ascentia Pharma Inc. filed Critical Jean-Pierre Pelletier
Priority to CA002171276A priority Critical patent/CA2171276C/en
Publication of CA2171276A1 publication Critical patent/CA2171276A1/en
Application granted granted Critical
Publication of CA2171276C publication Critical patent/CA2171276C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Abstract

Disclosed are the use of Human recombinant Interleukin-1 receptor antagonist and a composition containing the same for the preventive treatment of osteoarthritis, the Human recombinant Interleukin-1 receptor antagonist being effective for reducing the progression of lesions and cartilage degradation.
CA002171276A 1996-03-07 1996-03-07 Use of human recombinant interleukin-1 receptor antagonist and composition containing the latter for the treatment of osteoarthritis and composition containing said compound Expired - Fee Related CA2171276C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002171276A CA2171276C (en) 1996-03-07 1996-03-07 Use of human recombinant interleukin-1 receptor antagonist and composition containing the latter for the treatment of osteoarthritis and composition containing said compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002171276A CA2171276C (en) 1996-03-07 1996-03-07 Use of human recombinant interleukin-1 receptor antagonist and composition containing the latter for the treatment of osteoarthritis and composition containing said compound

Publications (2)

Publication Number Publication Date
CA2171276A1 true CA2171276A1 (en) 1997-09-08
CA2171276C CA2171276C (en) 2006-05-16

Family

ID=4157707

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002171276A Expired - Fee Related CA2171276C (en) 1996-03-07 1996-03-07 Use of human recombinant interleukin-1 receptor antagonist and composition containing the latter for the treatment of osteoarthritis and composition containing said compound

Country Status (1)

Country Link
CA (1) CA2171276C (en)

Also Published As

Publication number Publication date
CA2171276C (en) 2006-05-16

Similar Documents

Publication Publication Date Title
AU2582897A (en) Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation
AU1721697A (en) Use of compositions comprising stabilized biologically effective compounds
AU2053597A (en) Pharmaceutical compositions for the treatment of glaucoma
AU2205997A (en) Orthopedic implant
EP0956018A4 (en) Imidazole compounds, compositions and use
AU1911597A (en) Surgical retractor
AU2126097A (en) Dental compounds, compositions and products
AU1694497A (en) Disinfecting compositions and processes for disinfecting surfaces
EP0637450A3 (en) Composition for revitalizing scar tissue.
AU4984497A (en) Germicidal composition
AU4555097A (en) Compounds with antimycotic and cytostatic effect, preparation method, agent containing these compounds and dsm 11 092
AU5066598A (en) Dithiocarbonate composition
AU4133997A (en) Pharmaceutical composition for the treatment of syndrome x of reaven
AU2823097A (en) P1, p4-dithio-p2,p3-monochlorom ethylene 5', 5'''-diadenosine p1, p4-tetraphosphate as antithrombotic agent
AU2380595A (en) Biologically active composition
AU3918797A (en) Composition for the treatment of rice seeds
AU5594398A (en) Methods and compositions for preventing and treating bone loss
AU4994996A (en) Composition for the treatment of diarrhea, its use and its preparation
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
CA2171276A1 (en) Use of human recombinant interleukin-1 receptor antagonist and composition containing the latter for the treatment of osteoarthritis and composition containing said compound
AU2593597A (en) Compositions for the diagnosis and treatment of chediak-higashi syndrome
AU5791698A (en) Methods and compositions for preventing and treating bone loss
AU2036997A (en) Compositions containing starch excipients
AU6966998A (en) Composition for treating pain
AU2142197A (en) Water treatment compositions

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed